These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6999969)

  • 1. Adjuvant levamisole in the treatment of patients with resectable lung cancer.
    Amery WK
    Ann Clin Res; 1980; 12 Suppl 27():1-83. PubMed ID: 6999969
    [No Abstract]   [Full Text] [Related]  

  • 2. Final results of a multicenter placebo-controlled levamisole study of resectable lung cancer.
    Amery WK
    Cancer Treat Rep; 1978 Nov; 62(11):1677-83. PubMed ID: 365323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of immunomodulators in multimodal treatment of patients with lung cancer].
    Vagner VP; Voĭtkevich EG; Zakora GI; Chirvina ED
    Klin Med (Mosk); 1991 Dec; 69(12):55-9. PubMed ID: 1787682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levamisole: a double blind immunological study.
    Webster DJ; Whitehead RH; Richardson G; Hughes LE
    Anticancer Res; 1982; 2(1-2):29-32. PubMed ID: 7051958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic defects in lung cancer patients.
    Holmes EC; Golub SH
    J Thorac Cardiovasc Surg; 1976 Feb; 71(2):161-8. PubMed ID: 1107678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of levamisole on non-resected lung cancer--the results of randomized controlled study].
    Nishimura M; Morishita M; Urata A; Ota K
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1981-93. PubMed ID: 6307178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The skin tests in operability evaluation of patients with non-small cell cancer of the lungs].
    Biondo FG; Caldarelli L; Bergaminelli C; Perillo G
    Arch Monaldi Mal Torace; 1988; 43(3):265-70. PubMed ID: 2855917
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
    Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
    Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.
    Zhang Z; Xu F; Wang S; Li N; Wang C
    Lung Cancer; 2008 Jun; 60(3):434-40. PubMed ID: 18036699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind levamisole trial in resectable lung cancer.
    Amery WK
    Ann N Y Acad Sci; 1976; 277(00):260-8. PubMed ID: 793481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy of carcinoma of the lung].
    Sega E; Mineo TC; Rea SR; Sega FM; Ricci C
    Recenti Prog Med; 1978 Mar; 64(3):293-309. PubMed ID: 351751
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. I. A three-year clinical follow up.
    Padmanabhan TK; Balaram P; Vasudevan DM
    Neoplasma; 1987; 34(5):627-32. PubMed ID: 3696303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levamisole as an immunostimulant in primary lung cancer].
    Krzyśko R; Słowik-Gabryelska A
    Pneumonol Pol; 1981 Jan; 49(1):29-34. PubMed ID: 7291005
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunotherapy of cancer using levamisole, immunologic control of the post-surgical patient and graphic follow-up].
    de Carli HO; Llargues JM
    Rev Esp Oncol; 1980; 27(1):67-80. PubMed ID: 7209109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunochemotherapy of resectable lung cancer--a preliminary study on a comparison of the control, levamisole, and OK-432].
    Okayasu T; Kashimura Y; Matano J; Kawabata M; Takeoka T; Hashimoto M; Tanabe T
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1646-52. PubMed ID: 6764120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy with levamisole in resectable lung cancer.
    Amery WK; Cosemans J; Gooszen HC; Lopes Cardozo E; Louwagie A; Stam J; Swierenga J; Vanderschueren RG; Veldhuizen RW
    Recent Results Cancer Res; 1978; 68():268-77. PubMed ID: 379936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Herbal medicine compared with a placebo in adjuvant treatment of patients after radical operation for squamous cell carcinoma of the lung].
    Osterlind K; Hansen HH; Hansen M; Dombernowsky P
    Ugeskr Laeger; 1985 Jan; 147(3):156-60. PubMed ID: 3887710
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.
    Urist MM; Boddie AW; Townsend CM; Holmes EC
    J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levamisole versus placebo as an adjunct to primary therapy of laryngopharyngeal epidermoid carcinoma. Evaluation of the immune status.
    Mussche RA; Plum J; de Smedt M; Kluyskens P
    Acta Otorhinolaryngol Belg; 1977; 31(6):566-77. PubMed ID: 339662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.